SpringerLink
Log in

The Global Status and Control of Human Schistosomiasis: An Overview

  • Chapter
  • First Online:
Sino-African Cooperation for Schistosomiasis Control in Zanzibar

Part of the book series: Parasitology Research Monographs ((Parasitology Res. Monogr.,volume 15))

  • 328 Accesses

Abstract

Schistosomiasis is an ancient but highly debilitating disease. Currently, this infectious disease is identified as the second most devastating parasitic disease after malaria in terms of its morbidity and mortality and significant medical and veterinary importance in tropical and subtropical regions across the world. In this chapter, we describe the epidemiology, diagnosis, management, and control of human schistosomiasis. In addition, we propose the potential challenges during the progress towards elimination of schistosomiasis in this wormy world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 106.99
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 139.09
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info
Hardcover Book
EUR 213.99
Price includes VAT (Germany)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Bergquist R, Elmorshedy H (2018) Artemether and praziquantel: origin, mode of action, impact, and suggested application for effective control of human schistosomiasis. Trop Med Infect Dis 3:125

    Article  PubMed Central  Google Scholar 

  • Bergquist R, Utzinger J, Keiser J (2017) Controlling schistosomiasis with praziquantel: how much longer without a viable alternative? Infect Dis Poverty 6:74

    Article  PubMed  PubMed Central  Google Scholar 

  • Bergquist R, Yang GJ, Knopp S, Utzinger J, Tanner M (2015) Surveillance and response: tools and approaches for the elimination stage of neglected tropical diseases. Acta Trop 141:229–234

    Article  PubMed  Google Scholar 

  • Campbell SJ, Biritwum NK, Woods G, Velleman Y, Fleming F, Stothard JR (2018) Tailoring water, sanitation, and hygiene (WASH) targets for soil-transmitted helminthiasis and schistosomiasis control. Trends Parasitol 34:53–63

    Article  PubMed  Google Scholar 

  • Chen MG (1989) Progress and problems in schistosomiasis control in China. Trop Med Parasitol 40:174–176

    CAS  PubMed  Google Scholar 

  • Chun-Li C, Shi-Zhu L, **ao-Nong Z (2016) Impact of schistosomiasis transmission by catastrophic flood damage and emergency response in China. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi 28:618–623

    PubMed  Google Scholar 

  • Colley DG, Bustinduy AL, Secor WE, King CH (2014) Human schistosomiasis. Lancet 383:2253–2264

    Article  PubMed  PubMed Central  Google Scholar 

  • Deol AK, Fleming FM, Calvo-Urbano B, Walker M, Bucumi V, Gnandou I, Tukahebwa EM, Jemu S, Mwingira UJ, Alkohlani A, Traoré M, Ruberanziza E, Touré S, Basáñez MG, French MD, Webster JP (2019) Schistosomiasis—assessing progress toward the 2020 and 2025 global goals. N Engl J Med 381:2519–2528

    Article  PubMed  PubMed Central  Google Scholar 

  • Ferraz AA, Bacelar TS, Silveira MJ, Coelho AR, Câmara Neto RD, de Araújo Júnior JG, Ferraz EM (2001) Surgical treatment of schistosomal portal hypertension. Int Surg 86:1–8

    CAS  PubMed  Google Scholar 

  • GBD 2017 DALYs and HALE Collaborators (2018) Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1859–1922

    Article  PubMed Central  Google Scholar 

  • GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018) Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 392:1789–1858

    Article  Google Scholar 

  • Gray DJ, Ross AG, Li YS, McManus DP (2011) Diagnosis and management of schistosomiasis. BMJ d2651:342

    Google Scholar 

  • Guegan H, Fillaux J, Charpentier E, Robert-Gangneux F, Chauvin P, Guemas E, Boissier J, Valentin A, Cassaing S, Gangneux JP, Berry A, Iriart X (2019) Real-time PCR for diagnosis of imported schistosomiasis. PLoS Negl Trop Dis e0007711:13

    Google Scholar 

  • Hinz R, Schwarz NG, Hahn A, Frickmann H (2017) Serological approaches for the diagnosis of schistosomiasis—a review. Mol Cell Probes 31:2–21

    Article  CAS  PubMed  Google Scholar 

  • Inobaya MT, Olveda RM, Tallo V, McManus DP, Williams GM, Harn DA, Li Y, Chau TN, Olveda DU, Ross AG (2015) Schistosomiasis mass drug administration in the Philippines: lessons learnt and the global implications. Microbes Infect 17:6–15

    Article  PubMed  Google Scholar 

  • Kabuyaya M, Chimbari MJ, Mukaratirwa S (2018) Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review. Infect Dis Poverty 7:73

    Article  PubMed  PubMed Central  Google Scholar 

  • Keiser J, Silué KD, Adiossan LK, N'Guessan NA, Monsan N, Utzinger J, N'Goran EK (2014) Praziquantel, mefloquine-praziquantel, and mefloquine-artesunate-praziquantel against Schistosoma haematobium: a randomized, exploratory, open-label trial. PLoS Negl Trop Dis e2975:8

    Google Scholar 

  • King CH, Galvani AP (2018) Underestimation of the global burden of schistosomiasis. Lancet 391:307–308

    Article  PubMed  Google Scholar 

  • Leger E, Webster JP (2017) Hybridizations within the genus Schistosoma: implications for evolution, epidemiology and control. Parasitology 144:65–80

    Article  PubMed  Google Scholar 

  • Lin DD, Liu JX, Liu YM, Hu F, Zhang YY, Xu JM, Li JY, Ji MJ, Bergquist R, Wu GL, Wu HW (2008) Routine Kato-Katz technique underestimates the prevalence of Schistosoma japonicum: a case study in an endemic area of the People’s Republic of China. Parasitol Int 57:281–286

    Article  PubMed  Google Scholar 

  • LoVerde PT (2019) Schistosomiasis. Adv Exp Med Biol 1154:45–70

    Article  PubMed  Google Scholar 

  • McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN (2018) Schistosomiasis. Nat Rev Dis Primers 4:13

    Article  PubMed  Google Scholar 

  • Mutapi F, Maizels R, Fenwick A, Woolhouse M (2017) Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 17:e42–e48

    Article  PubMed  Google Scholar 

  • Nelwan ML (2019) Schistosomiasis: life cycle, diagnosis, and control. Curr Ther Res Clin Exp 91:5–9

    Article  PubMed  PubMed Central  Google Scholar 

  • Olveda DU, Li Y, Olveda RM, Lam AK, McManus DP, Chau TN, Harn DA, Williams GM, Gray DJ, Ross AG (2014a) Bilharzia in the Philippines: past, present, and future. Int J Infect Dis 18:52–56

    Article  PubMed  Google Scholar 

  • Olveda DU, Olveda RM, Lam AK, Chau TN, Li Y, Gisparil AD 2nd, Ross AG (2014b) Utility of diagnostic imaging in the diagnosis and management of schistosomiasis. Clin Microbiol 3:142

    Article  PubMed  PubMed Central  Google Scholar 

  • Poulton K, Webster B (2018) Development of a lateral flow recombinase polymerase assay for the diagnosis of Schistosoma mansoni infections. Anal Biochem 546:65–71

    Article  CAS  PubMed  Google Scholar 

  • Qian C, Zhang Y, Zhang X, Yuan C, Gao Z, Yuan H, Zhong J (2018) Effectiveness of the new integrated strategy to control the transmission of Schistosoma japonicum in China: a systematic review and meta-analysis. Parasite 25:54

    Article  PubMed  PubMed Central  Google Scholar 

  • Rollinson D, Knopp S, Levitz S, Stothard JR, Tchuem Tchuenté LA, Garba A, Mohammed KA, Schur N, Person B, Colley DG, Utzinger J (2013) Time to set the agenda for schistosomiasis elimination. Acta Trop 128:423–440

    Article  PubMed  Google Scholar 

  • Ross AG, Chau TN, Inobaya MT, Olveda RM, Li Y, Harn DA (2017) A new global strategy for the elimination of schistosomiasis. Int J Infect Dis 54:130–137

    Article  CAS  PubMed  Google Scholar 

  • Sanogo B, Yuan D, Zeng X, Zhang Y, Wu Z (2018) Diversity and compatibility of human schistosomes and their intermediate snail hosts. Trends Parasitol 34(6):493–510

    Article  PubMed  Google Scholar 

  • Secor WE (2015) Early lessons from schistosomiasis mass drug administration programs. F1000Res 4:F1000 Faculty Rev-1157

    Google Scholar 

  • Shu K, Zhang S, Han L, Lei T (2009) Surgical treatment of cerebellar schistosomiasis. Neurosurgery 64:941–944

    Article  PubMed  Google Scholar 

  • Song LG, Wu XY, Sacko M, Wu ZD (2016) History of schistosomiasis epidemiology, current status, and challenges in China: on the road to schistosomiasis elimination. Parasitol Res 115:4071–4081

    Article  PubMed  Google Scholar 

  • Song Z, Ting L, Kun Y, Wei L, Jian-Feng Z, Li-Chuan G, Yan-Hong L, Yang D, Qing-Jie Y, Hai-Tao Y (2018) Establishment of a recombinase-aided isothermal amplification technique to detect Schistosoma japonicum specific gene fragments. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi 30:273–277

    PubMed  Google Scholar 

  • Tambo E, Ai L, Zhou X, Chen JH, Hu W, Bergquist R, Guo JG, Utzinger J, Tanner M, Zhou XN (2014) Surveillance-response systems: the key to elimination of tropical diseases. Infect Dis Poverty 3:17

    Article  PubMed  PubMed Central  Google Scholar 

  • Tchuem Tchuenté LA, Rollinson D, Stothard JR, Molyneux D (2017) Moving from control to elimination of schistosomiasis in sub-Saharan Africa: time to change and adapt strategies. Infect Dis Poverty 6:42

    Article  PubMed  PubMed Central  Google Scholar 

  • Tebeje BM, Harvie M, You H, Loukas A, McManus DP (2016) Schistosomiasis vaccines: where do we stand? Parasit Vectors 9:528

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Toor J, Rollinson D, Turner HC, Gouvras A, King CH, Medley GF, Hollingsworth TD, Anderson RM (2020) Achieving elimination as a public health problem for Schistosoma mansoni and S. haematobium: when is community-wide treatment required? J Infect Dis 221:S525–S530

    Article  PubMed  Google Scholar 

  • Van Dorssen CF, Gordon CA, Li Y, Williams GM, Wang Y, Luo Z, Gobert GN, You H, McManus DP, Gray DJ (2017) Rodents, goats and dogs—their potential roles in the transmission of schistosomiasis in China. Parasitology 144:1633–1642

    Article  Google Scholar 

  • Vicente B, López-Abán J, Muro A (2018) Field and laboratory comparative evaluation of a LAMP assay for the diagnosis of urogenital schistosomiasis in Cubal, Central Angola. Tropical Med Int Health 23:992–1001

    Article  CAS  Google Scholar 

  • Wang W, Liang YS, Hong QB, Dai JR (2013) African schistosomiasis in mainland China: risk of transmission and countermeasures to tackle the risk. Parasit Vectors 6:249

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang W, Wang L, Liang YS (2012) Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 111:1871–1877

    Article  PubMed  Google Scholar 

  • Wang W, Yang K (2020) Schistosomiasis and the global goals. N Engl J Med 382:1575–1576

    Article  PubMed  Google Scholar 

  • Wang XY, He J, Juma S, Kabole F, Guo JG, Dai JR, Li W, Yang K (2019) Efficacy of China-made praziquantel for treatment of schistosomiasis haematobium in Africa: a randomized controlled trial. PLoS Negl Trop Dis e0007238:13

    Google Scholar 

  • Wu W, Feng A, Huang Y (2015) Research and control of advanced schistosomiasis japonica in China. Parasitol Res 114:17–27

    Article  PubMed  Google Scholar 

  • Wu W, Wang W, Huang YX (2011) New insight into praziquantel against various developmental stages of schistosomes. Parasitol Res 109:1501–1507

    Article  PubMed  Google Scholar 

  • Wu ZL, He L (2013) Advances in traditional Chinese medicine treatment of schistosomiasis liver fibrosis. Zhongguo Xue ** Chong Bing Fang Zhi Za Zhi 25:422–424

    PubMed  Google Scholar 

  • **ao SH (2013) Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies. Parasitol Res 112:3723–3740

    Article  PubMed  Google Scholar 

  • Xu J, Li SZ, Zhang LJ, Bergquist R, Dang H, Wang Q, Lv S, Wang TP, Lin DD, Liu JB, Ren GH, Yang K, Liu Y, Dong Y, Zhang SQ, Zhou XN (2020) Surveillance-based evidence: elimination of schistosomiasis as a public health problem in the Peoples' Republic of China. Infect Dis Poverty 9:63

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang XG, Li GX, Zhao SS, Xu FL, Wang YH, Wang W (2014) A review of dihydroartemisinin as another gift from traditional Chinese medicine not only for malaria control but also for schistosomiasis control. Parasitol Res 113:1769–1773

    Article  PubMed  Google Scholar 

  • Zhou XN, Bergquist R, Leonardo L, Yang GJ, Yang K, Sudomo M, Olveda R (2010) Schistosomiasis japonica control and research needs. Adv Parasitol 72:145–178

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was funded by the grants from Jiangsu Provincial Department of Science and Technology (grant No. BZ2020003), Jiangsu Provincial Commission of Health (grant Nos. ZDRCA2016056, QNRC2016621 and H2018097), and Wuxi Municipal Bureau of Science and Technology (grant No. CSE31N1730).

Author information

Authors and Affiliations

  1. Key Laboratory of National Health Commission on Parasitic Disease Prevention and Control, Jiangsu Provincial Key Laboratory of Parasites and Vector Control Technology, Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu Province, China

    Wei Wang & Kun Yang

  2. School of Public Health, Nan**g Medical University, Nan**g, Jiangsu Province, China

    Kun Yang

Authors
  1. Wei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kun Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wei Wang .

Editor information

Editors and Affiliations

  1. Jiangsu Institute of Parasitic Diseases, Wuxi, Jiangsu, China

    Kun Yang

  2. Department of Parasitology, Heinrich Heine University, Düsseldorf, Germany

    Heinz Mehlhorn

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Wang, W., Yang, K. (2021). The Global Status and Control of Human Schistosomiasis: An Overview. In: Yang, K., Mehlhorn, H. (eds) Sino-African Cooperation for Schistosomiasis Control in Zanzibar. Parasitology Research Monographs, vol 15. Springer, Cham. https://doi.org/10.1007/978-3-030-72165-7_3

Download citation

Publish with us

Policies and ethics

Search

Navigation